
Armando Orlandi/photos.asco.org
Apr 12, 2025, 14:54
Armando Orlandi: Sentinel Lymph Node Biopsy Can Be Skipped in Many Early Breast Cancers
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on X:
“Cowabunga!
Riding Breast Cancer’s Biggest Data’s Wave
New ASCO guidelines say we can SKIP SLNB in many early breast cancers!
SOUND and INSEMA trials show it’s safe for postmenopausal Wives with ER+/HER2- tumors ≤2cm and normal ultrasound.
Less surgery, same outcomes!”
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update
Authors: Ko Un Park, et al.
More posts featuring Armando Orlandi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 12, 2025, 19:25
Apr 12, 2025, 19:14
Apr 12, 2025, 19:10
Apr 12, 2025, 18:52
Apr 12, 2025, 18:48